Community pharmacists' interventions in asthma care: A descriptive study

Annals of Pharmacotherapy

Volumn 43, Issue 1, 2009, Pages 104-111

  René Henri, Nola ^a   Khamla, Yvonne ^b   Nadaira, Natalie ^c   Ouellet, Catherine ^d   Blais, Lucie ^e,f   Lalonde, Lyne ^e,g   Collin, Johanne ^e   Beauchesne, Marie France ^e,f  

^a Pharmacie Yves Pichette   (Canada)

^b Pharmacie David Fortin   (Canada)

^c Jean Francois Guevin Pharmacy   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^g Centre de Sante et de Services Sociaux de Laval   (Canada)

Author keywords

Asthma; Community practice; Pharmacy practice

Indexed keywords

ANTIASTHMATIC AGENT;

ADULT; ARTICLE; ASTHMA; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MALE; PATIENT CARE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; COMPARATIVE STUDY; MIDDLE AGED; PATIENT EDUCATION; PHARMACY; PROCEDURES; PROFESSIONAL STANDARD; TIME; UTILIZATION;

ADULT; ASTHMA; COMMUNITY PHARMACY SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROFESSIONAL ROLE; QUESTIONNAIRES; TIME FACTORS;

EID: 58549093177     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L308     Document Type: Article

References (24)

1. Statistique Canada. Enquête sur la santé dans les collectivités canadiennes (ESCC 3.1) 2005 - Tableau CANSIM 105-0401: Asthme, selon le groupe d'âge et le sexe, population à domicile de 12 ans et plus, Canada, provinces, territoires, régions sociosanitaires (limites de juin 2005) et groupes de régions homologues, données aux 2 ans. http:/cansim2.statcan.ca/cgi-win (accessed 2007 May 24).
2. Seung SJ, Mittmann N. Urgent care costs of uncontrolled asthma in Canada, 2004. Can Respir J 2005;12:435-6.
3. Global Asthma Physician and Patient Survey. Global adult highlights 2005. www.gappsurveyorg/healthcare-key-findings.html (accessed 2008 Jul 13).
4. FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR. Asthma control in Canada remains suboptimal: The Reality of Asthma Control (TRAC) study. Can Respir J 2006;13:253-9.
5. McLean W, Waller R, Gillis J. The BC community pharmacy asthma study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J 2003;10:195-202.
6. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001;21:1196-203.
7. Herborg H, Soenfdergaard B, Froekjaer B, et al. Improving drug therapy for patients with asthma: part 1. J Am Pharm Assoc 2001;41:539-50.
8. Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008;31:790-9. Epub 19 Dec 2007.
9. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002;288:1594-602.
10. Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc 2002;42:743-52.
11. Burkiewicz JS, Zgarrick DP. Evidence-based practice by pharmacists: utilization and barriers. Ann Pharmacother 2005;39:1214-9. Epub 14 Jun 2005. DOI 10.1345/aph.1E663
12. Brown CM, Barner JC, Shepherd MD. Issues and barriers related to the provision of pharmaceutical care in community health centers and migrant health centers. J Am Pharm Assoc 2003;43:75-7.
13. O'Loughlin J, Masson P, Déry V, Fagnan D. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 1999;28:324-31.
14. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc 1997;37:535-42.
15. Amsler MR, Murray MD, Tierney WM, et al. Pharmaceutical care in chain pharmacies: beliefs and attitudes of pharmacists and patients. J Am Pharm Assoc 2001;41:850-5.
16. McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandingham J, Sobotka J. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc 1998;38:87-95.
17. Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Admin Pharm 1998;15:284-95.
18. Rouleau R, Beauchesne MF, Laurier C. Impact of a continuing education program on community pharmacists' interventions and asthma medication use: a pilot study. Ann Pharmacother 2007;41:574-80. Epub 27 Mar 2007. DOI 10.1345/aph.1H606
19. Dunlop JA, Shaw JP. Community pharmacists' perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci 2002;24:224-30.
20. Ordre des pharmaciens du Québec. Rapport annuel 2005-2006.
21. Association Québécoise des pharmaciens proprié taires. Rapport d'activité 2005-2006.
22. Ordre des pharmaciens du Québec. Guide de pratique. Rapport annuel 2005-2006.
23. Global Initiative for Asthma. Global strategy for asthma management and prevention. www.ginasthma.org (accessed 2007 May 24).
24. Kröger E, Moisan J, Grégoire JP. Billing for cognitive services: understanding Québec pharmacists' behavior. Ann Pharmacother 2000;34:309-16. DOI 10.1345/aph.19133